NVDA
NVIDIA
-- 134.850 TSLA
Tesla
-- 472.975 QUBT
Quantum Computing
-- 20.881 RGTI
Rigetti Computing
-- 11.4000 PLTR
Palantir
-- 75.600 
Finally released?
Finally released?
A new drug application (NDA) for TNX-102 SL for the management of fibromyalgia has been submitted to the FDA, with NDA acceptance expected in December 2024. The FDA has previously granted fast track designation, and a decision regarding FDA approval in 2025 is anticipated.
If approved by the FDA, TNX-102 SL will become the first member of a new group of analgesics for fibromyalgia and will be reintroduced after more than 15 years as a new medication for fibromyalgia treatment 🌸.
If approved by the FDA, TNX-102 SL will become the first member of a new group of analgesics for fibromyalgia and will be reintroduced after more than 15 years as a new medication for fibromyalgia treatment 🌸.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
ペニー株大好き : I currently own 10,000 shares. I hope for a skyrocketing. The hope of fibromyalgia patients
And, also, here and$Annovis Bio (ANVS.US)$
I am currently focusing on this. Looking forward to the revolutionary new drug for Alzheimer's.
うおやさん : Just a sixth sense without any basis, I bought 300,000 shares (around 25 yen per share). I hope it pays off~